GMAB

GENMAB A/S

OTC · Pharmaceutical Preparations · CIK 0001434265

$25.08 -0.63% $16.1B

High Impact Filing (7/10)11 New Institutional Positions8 Institutional Exits

Vol

Market Cap$16.1B

Cap SizeLarge Cap

Analyst ConsensusStrong Buy (76%)

Inst. Holders50 funds

Inst. Value$1.2B

Inst. Activity11 buys / 8 sells

SEC Reports3

Exchange OTC·Sector Pharmaceutical Preparations·CIK 0001434265·Prev Close $25.24

Recent Activity

Jun 11, 2026 SEC

Genmab A/S filed a 6-K reporting a routine grant of 15,894 restricted stock units and 15,494 warrants to employees. The

6-K — Impact 2/10

Jun 11, 2026 SEC

An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added $21.8M in new holdin

INST-CLUSTER — Impact 4/10

Jun 5, 2026 short_volume

Short Volume: GMAB — 64.1% short (0.5M / 0.8M)

Short: 518,971 | Exempt: 73 | TRF Vol: 809,637 | Short Ratio: 64.1% | Off-exchange volume (dark pool

Feb 28, 2026 SEC

Three major passive institutions — Morgan Stanley, Schwab, and UBS — significantly increased their positions in Genmab A

INST-CLUSTER — Impact 7/10

Inst.

RENAISSANCE TECHNOLOGIES LLC — ADD

4,414,550 shares ($118.4M)

Inst.

FIRST TRUST ADVISORS LP — ADD

2,461,342 shares ($66.0M)

Price Targets

$36.82 +46.8% upside Strong Buy

Current $25.08 Low $32.00 Median $38.00 High $41.50 11 analysts

$32.00 $41.50

Analyst Ratings

Buy76% buy · 25 analysts

5Strong Buy

14Buy

4Hold

1Sell

1Strong Sell

Recent Analyst Actions

Date	Firm	Action	Rating
Apr 30, 2026	HC Wainwright & Co.	MAINTAIN	Buy → Buy
Mar 27, 2026	Wolfe Research	INITIATE	Outperform
Mar 2, 2026	Wells Fargo	INITIATE	Overweight
Feb 23, 2026	Guggenheim	MAINTAIN	Buy → Buy
Feb 18, 2026	HC Wainwright & Co.	MAINTAIN	Buy → Buy

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$0.30 ▼ -3.6%	$0.24 — $0.38	-44% YoY	5
Next Q	$0.31 ▼ -8.3%	$0.26 — $0.37	-52% YoY	5
Current FY	$1.04 ▼ -12.0%	$0.92 — $1.25	-32% YoY	5
Next FY	$1.83 ▼ -4.1%	$1.53 — $2.08	76% YoY	5

Latest Reports

NEUTRAL 6-K 2/10

Genmab A/S filed a 6-K reporting a routine grant of 15,894 restricted stock units and 15,494 warrants to employees. The

Jun 11, 2026

BEARISH INST-CLUSTER 4/10

An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added $21.8M in new holdin

Jun 11, 2026

Top Institutional Holders

Fund	Value	Move
NOMURA ASSET MANAGEMENT CO	—	—
ALLIANCEBERNSTEIN L.P.	$294.4M	—
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$133.5M	ADD
BlackRock, Inc.	$121.7M	ADD
RENAISSANCE TECHNOLOGIES LLC	$118.4M	ADD

50 institutional holders with $1.2B total value (41,582,714 shares) as of 2026-Q1. Top holders: NOMURA, ALLIANCEBERNSTEIN, ARROWSTREET. Net buying activity: 11 institutions added/increased vs 8 reduced.

Top Institutional Holders — 2026-Q1

#	Fund	Shares	Value	% of Tracked	Last Move
1	NOMURA ASSET MANAGEMENT CO LTD	—	$0.00	0.0%	—
2	ALLIANCEBERNSTEIN L.P.	9,557,149	$294.4M	25.5%	—
3	ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	4,975,324	$133.5M	11.6%	ADD +36.6%
4	BlackRock, Inc.	4,536,565	$121.7M	10.6%	ADD +33.1%
5	RENAISSANCE TECHNOLOGIES LLC	4,414,550	$118.4M	10.3%	ADD +26.4%
6	FIRST TRUST ADVISORS LP	2,461,342	$66.0M	5.7%	ADD +84.3%
7	TWO SIGMA INVESTMENTS, LP	2,339,432	$62.8M	5.4%	TRIM -35.6%
8	MORGAN STANLEY	2,184,701	$58.6M	5.1%	TRIM -37.9%
9	FEDERATED HERMES, INC.	1,251,590	$33.6M	2.9%	ADD +84.2%
10	FRANKLIN RESOURCES INC	1,193,145	$32.0M	2.8%	DOUBLED +3792.8%
11	Pictet Asset Management Holding SA	1,077,471	$28.9M	2.5%	NEW
12	FMR LLC	1,011,726	$27.1M	2.4%	ADD +64.5%
13	GOLDMAN SACHS GROUP INC	931,259	$25.0M	2.2%	—
14	ENVESTNET ASSET MANAGEMENT INC	862,301	$23.1M	2.0%	—
15	Russell Investments Group, Ltd.	797,068	$21.4M	1.9%	—
16	Alyeska Investment Group, L.P.	645,481	$17.3M	1.5%	ADD +27.4%
17	CIBC WORLD MARKET INC.	488,266	$13.1M	1.1%	ADD +32.9%
18	WELLS FARGO & COMPANY/MN	319,592	$8.6M	0.7%	DOUBLED +347.9%
19	Hudson Bay Capital Management LP	310,000	$8.3M	0.7%	—
20	BANK OF AMERICA CORP /DE/	241,520	$6.5M	0.6%	TRIM -28.9%

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
RENAISSANCE TECHNOLOGIES LLC	ADD	3,492,850	4,414,550	+26.4%	$118.4M	2026-Q1
FIRST TRUST ADVISORS LP	ADD	1,335,273	2,461,342	+84.3%	$66.0M	2026-Q1
FEDERATED HERMES, INC.	ADD	679,379	1,251,590	+84.2%	$33.6M	2026-Q1
FRANKLIN RESOURCES INC	DOUBLED	30,650	1,193,145	+3792.8%	$32.0M	2026-Q1
Alyeska Investment Group, L.P.	ADD	506,661	645,481	+27.4%	$17.3M	2026-Q1
CIBC WORLD MARKET INC.	ADD	367,282	488,266	+32.9%	$13.1M	2026-Q1
BANK OF AMERICA CORP /DE/	TRIM	339,917	241,520	-28.9%	$6.5M	2026-Q1
STIFEL FINANCIAL CORP	ADD	39,931	79,105	+98.1%	$2.1M	2026-Q1
Vestmark Advisory Solutions, Inc.	TRIM	109,358	59,306	-45.8%	$1.6M	2026-Q1
CAPTRUST FINANCIAL ADVISORS	TRIM	50,435	25,515	-49.4%	$684.6K	2026-Q1
Rockefeller Capital Management L.P.	ADD	12,572	16,073	+27.8%	$431.2K	2026-Q1
MARSHALL WACE, LLP	NEAR_EXIT	358,440	15,000	-95.8%	$402.4K	2026-Q1
Allspring Global Investments Holdings, LLC	ADD	7,131	9,117	+27.9%	$246.8K	2026-Q1
CWM, LLC	DOUBLED	2,739	8,668	+216.5%	$232.6K	2026-Q1
GLENMEDE TRUST CO NA	TRIM	14,843	7,771	-47.6%	$208.5K	2026-Q1
M&T BANK CORP	TRIM	15,034	7,600	-49.4%	$203.9K	2026-Q1
BROWN BROTHERS HARRIMAN & CO	DOUBLED	160	1,646	+928.8%	$44.2K	2026-Q1
Woodline Partners LP	EXIT	369,188	0	-100.0%	$0.00	2026-Q1
BALYASNY ASSET MANAGEMENT L.P.	EXIT	379,364	0	-100.0%	$0.00	2026-Q1
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	ADD	3,643,139	4,978,058	+36.6%	$153.3M	2025-Q4
BlackRock, Inc.	ADD	3,450,526	4,593,901	+33.1%	$141.5M	2025-Q4
Pictet Asset Management Holding SA	NEW	—	1,098,550	—	$33.8M	2025-Q4
TWO SIGMA INVESTMENTS, LP	TRIM	1,391,215	895,843	-35.6%	$27.6M	2025-Q4
FEDERATED HERMES, INC.	ADD	422,938	679,379	+60.6%	$20.9M	2025-Q4
Alyeska Investment Group, L.P.	NEW	—	506,661	—	$15.6M	2025-Q4

∅

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

3 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 4.3/10.

NEUTRAL 6-K 2/10

Genmab A/S filed a 6-K reporting a routine grant of 15,894 restricted stock units and 15,494 warrant

Jun 11, 2026

BEARISH INST-CLUSTER 4/10

An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added

Jun 11, 2026

BULLISH INST-CLUSTER 7/10

Three major passive institutions — Morgan Stanley, Schwab, and UBS — significantly increased their p

Feb 28, 2026

∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (76% buy). Based on 25 analysts: 5 strong buy, 14 buy, 4 hold, 1 sell, 1 strong sell.

Analyst Price Targets

$36.82 mean target +46.8% upside Strong Buy (1.36)

$32.00 Low $41.50 High

Metric	Value
Current Price	$25.08
Target Low	$32.00
Target Mean	$36.82
Target Median	$38.00
Target High	$41.50
# Analysts	11
Recommendation	Strong Buy (1.36)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$0.30	$0.24	$0.38	-44.2%	-3.6%	1↑ 1↓	$7.0B	17.3%	5
Next Q 2026-09-30	$0.31	$0.26	$0.37	-51.8%	-8.3%	1↑ 1↓	$7.3B	10.7%	5
Current FY 2026-12-31	$1.04	$0.92	$1.25	-32.3%	-12.0%	1↑ 1↓	$27.6B	17.6%	5
Next FY 2027-12-31	$1.83	$1.53	$2.08	75.8%	-4.1%	0↑ 2↓	$32.4B	17.3%	5

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$0.302
7d ago	$0.316	-0.013
30d ago	$0.314	-0.011
60d ago	$0.275	+0.027
90d ago	$0.280	+0.022

4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.

Individual Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Apr 30, 2026	HC Wainwright & Co.	MAINTAIN	Buy	Buy
Mar 27, 2026	Wolfe Research	INITIATE	—	Outperform
Mar 2, 2026	Wells Fargo	INITIATE	—	Overweight
Feb 23, 2026	Guggenheim	MAINTAIN	Buy	Buy
Feb 18, 2026	HC Wainwright & Co.	MAINTAIN	Buy	Buy
Jan 28, 2026	HC Wainwright & Co.	REITERATE	Buy	Buy
Jan 20, 2026	HC Wainwright & Co.	MAINTAIN	Buy	Buy

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Sell	Strong Sell	Buy %
Jun 1, 2026	5	14	4	1	1	76%
May 1, 2026	5	14	6	1	1	70%
Apr 1, 2026	5	12	8	1	1	63%
Mar 1, 2026	5	11	8	1	1	62%
Feb 1, 2026	4	12	8	1	1	62%
Jan 1, 2026	3	13	9	1	1	59%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 12, 2026

Clinical Trial

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

Phase Phase 2 — TERMINATED

Jun 5, 2026

short_volume

Short Volume: GMAB — 64.1% short (0.5M / 0.8M)

Short: 518,971 | Exempt: 73 | TRF Vol: 809,637 | Short Ratio: 64.1% | Off-exchange volume (dark pool + OTC)

Jun 2, 2026

Clinical Trial

PRO1107 in Patients With Advanced Solid Tumors

Phase Phase 2 — TERMINATED

Jun 2, 2026

short_volume

Short Volume: GMAB — 59.9% short (0.7M / 1.2M)

Short: 693,301 | Exempt: 12,919 | TRF Vol: 1,157,757 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)

Jun 1, 2026

short_volume

Short Volume: GMAB — 65.5% short (0.5M / 0.7M)

Short: 461,044 | Exempt: 3,026 | TRF Vol: 703,452 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)

May 29, 2026

short_volume

Short Volume: GMAB — 58.3% short (0.3M / 0.5M)

Short: 320,089 | Exempt: 24,988 | TRF Vol: 549,249 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)

May 20, 2026

short_volume

Short Volume: GMAB — 77.2% short (0.7M / 0.9M)

Short: 674,724 | Exempt: 24,159 | TRF Vol: 874,186 | Short Ratio: 77.2% | Off-exchange volume (dark pool + OTC)

May 18, 2026

short_volume

Short Volume: GMAB — 79.2% short (0.9M / 1.1M)

Short: 903,397 | Exempt: 25,655 | TRF Vol: 1,141,178 | Short Ratio: 79.2% | Off-exchange volume (dark pool + OTC)

May 15, 2026

short_volume

Short Volume: GMAB — 83.4% short (0.5M / 0.6M)

Short: 466,178 | Exempt: 0 | TRF Vol: 558,733 | Short Ratio: 83.4% | Off-exchange volume (dark pool + OTC)

May 13, 2026

short_volume

Short Volume: GMAB — 66.8% short (0.4M / 0.6M)

Short: 383,549 | Exempt: 6,959 | TRF Vol: 573,923 | Short Ratio: 66.8% | Off-exchange volume (dark pool + OTC)

May 12, 2026

short_volume

Short Volume: GMAB — 77.1% short (0.4M / 0.6M)

Short: 441,197 | Exempt: 14,428 | TRF Vol: 572,006 | Short Ratio: 77.1% | Off-exchange volume (dark pool + OTC)

May 11, 2026

short_volume

Short Volume: GMAB — 73.1% short (0.6M / 0.8M)

Short: 591,137 | Exempt: 13,503 | TRF Vol: 808,678 | Short Ratio: 73.1% | Off-exchange volume (dark pool + OTC)

May 8, 2026

short_volume

Short Volume: GMAB — 75.1% short (1.3M / 1.7M)

Short: 1,310,080 | Exempt: 76,703 | TRF Vol: 1,743,885 | Short Ratio: 75.1% | Off-exchange volume (dark pool + OTC)

Apr 22, 2026

short_volume

Short Volume: GMAB — 59.7% short (0.3M / 0.5M)

Short: 303,160 | Exempt: 521 | TRF Vol: 507,630 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)

Apr 20, 2026

short_volume

Short Volume: GMAB — 84.3% short (0.6M / 0.7M)

Short: 596,437 | Exempt: 25,934 | TRF Vol: 707,451 | Short Ratio: 84.3% | Off-exchange volume (dark pool + OTC)

Apr 13, 2026

short_interest

FTD: GMAB — 51,642 shares ($1.5M) failed to deliver

Settlement: 20260413, Price: $28.25, FTD Value: $1,458,886.5, GENMAB A/S ADS (SPONSORED) (DN

Apr 10, 2026

short_volume

Short Volume: GMAB — 76.5% short (0.5M / 0.7M)

Short: 544,595 | Exempt: 1,311 | TRF Vol: 712,230 | Short Ratio: 76.5% | Off-exchange volume (dark pool + OTC)